DNDN

Bold Day for Bank of America — Thursday’s IP Market Recap

Bank of America shares clear $6 for the first time since November, and other U.S. banking giants make gains. Automakers, Dendreon also charge ahead. More 

Dendreon Jumps 40% on Provenge Sales

Dendreon saw its stock jump Thursday as sales of its cancer drug beat the expectations of both analysts and the company itself. More 

Boeing Rewrites Its Own Record — Thursday’s IP Market Recap

Boeing (BA) signed a $21.7B deal with Indonesia's Lion Air on Thursday, breaking a company mark it set earlier this week. Also, J.M. Smucker (SJM) disappointed. More 

Medivation Shares Shoot Up on Prostate Cancer Treatment News

Medivation (MDVN) gains almost 140% Thursday on encouraging results for its prostate cancer treatment, and Dendreon (DNDN) is further battered. More 

Pharma, Fashion Fallout — Thursday’s IP Market Recap

Dendreon (DNDN), Abercrombie & Fitch (ANF) watched their stocks plummet Thursday after each doled out bad news. More 

Why Dendreon Is Aiming Prostate Drug Pitches to Consumers

Dendreon (DNDN) appears to be pulling out all the stops in an effort to restore at least some of the luster to its prostate cancer treatment Provenge. More